These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 2952419

  • 1. Diabetic cataracts in animal models: prevention and reversibility with aldose reductase inhibitors.
    Kador PF, Akagi Y, Kinoshita JH.
    Diabet Med; 1985 May; 2(3):194-6. PubMed ID: 2952419
    [No Abstract] [Full Text] [Related]

  • 2. The effect of aldose reductase and its inhibition on sugar cataract formation.
    Kador PF, Akagi Y, Kinoshita JH.
    Metabolism; 1986 Apr; 35(4 Suppl 1):15-9. PubMed ID: 3083204
    [Abstract] [Full Text] [Related]

  • 3. [Effects of M79175, an aldose reductase inhibitor, on experimental sugar cataracts].
    Ono H, Nozawa Y, Hayano S.
    Nippon Ganka Gakkai Zasshi; 1982 Apr; 86(9):1343-50. PubMed ID: 6818854
    [No Abstract] [Full Text] [Related]

  • 4. Altering the course of cataracts in diabetic rats.
    Fukushi S, Merola LO, Kinoshita JH.
    Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):313-5. PubMed ID: 6766909
    [Abstract] [Full Text] [Related]

  • 5. Cataract prevention in diabetic Octodon degus with Pfizer's sorbinil.
    Datiles MB, Fukui H.
    Curr Eye Res; 1989 Mar; 8(3):233-7. PubMed ID: 2523284
    [Abstract] [Full Text] [Related]

  • 6. Nonosmotic diabetic cataracts.
    Malone JI, Lowitt S, Cook WR.
    Pediatr Res; 1990 Mar; 27(3):293-6. PubMed ID: 2138728
    [Abstract] [Full Text] [Related]

  • 7. Properties of ICI 128,436, a novel aldose reductase inhibitor, and its effects on diabetic complications in the rat.
    Stribling D, Mirrlees DJ, Harrison HE, Earl DC.
    Metabolism; 1985 Apr; 34(4):336-44. PubMed ID: 3920474
    [Abstract] [Full Text] [Related]

  • 8. Aldose reductase in diabetic cataracts.
    Kinoshita JH, Kador P, Catiles M.
    JAMA; 1981 Jul 17; 246(3):257-61. PubMed ID: 6787220
    [No Abstract] [Full Text] [Related]

  • 9. Reversal of diabetic cataract by sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A, Cruz E.
    Diabetes; 1985 Jan 17; 34(1):15-21. PubMed ID: 3917257
    [Abstract] [Full Text] [Related]

  • 10. Lens metabolism and cellular effects of aldose reductase.
    McLean P, Gonzalez AM, Sochor M, Hothersall JS.
    Diabet Med; 1985 May 17; 2(3):189-93. PubMed ID: 2952418
    [No Abstract] [Full Text] [Related]

  • 11. Raman spectroscopic study of the effect of aldose reductase inhibitor on experimental diabetic cataract.
    Nozawa H, Yaginuma T, Mizuno A.
    Nippon Ganka Gakkai Zasshi; 1988 Jan 17; 92(1):194-201. PubMed ID: 3133929
    [No Abstract] [Full Text] [Related]

  • 12. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF, Lee JW, Fujisawa S, Blessing K, Lou MF.
    J Ocul Pharmacol Ther; 2000 Apr 17; 16(2):149-60. PubMed ID: 10803425
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of polyol pathway activity in diabetic and galactosemic rats by the aldose reductase inhibitor CP-45,634.
    Peterson MJ, Sarges R, Aldinger CE, MacDonald DP.
    Adv Exp Med Biol; 1979 Apr 17; 119():347-56. PubMed ID: 115231
    [No Abstract] [Full Text] [Related]

  • 14. Some effects of aldose reductase inhibition upon the eyes of long-term streptozotocin-diabetic rats.
    Poulsom R, Boot-Handford RP, Heath H.
    Curr Eye Res; 1979 Apr 17; 2(5):351-5. PubMed ID: 6819916
    [No Abstract] [Full Text] [Related]

  • 15. Aldose reductase and the etiology of diabetic cataracts.
    Varma SD.
    Curr Top Eye Res; 1980 Apr 17; 3():91-155. PubMed ID: 6807610
    [No Abstract] [Full Text] [Related]

  • 16. [Aldose-reductase inhibitors and cataract formation (author's transl)].
    Keller G, Leuenberger PM.
    Klin Monbl Augenheilkd; 1980 Apr 17; 176(4):514-5. PubMed ID: 6775130
    [Abstract] [Full Text] [Related]

  • 17. Effects of two new aldose reductase inhibitors, AL-1567 and AL-1576, in diabetic rats.
    Griffin BW, McNatt LG, Chandler ML, York BM.
    Metabolism; 1987 May 17; 36(5):486-90. PubMed ID: 3106757
    [Abstract] [Full Text] [Related]

  • 18. Effect of aldose reductase inhibitor on experimental diabetic cataract monitored by laser Raman spectroscopy.
    Mizuno A, Nozawa H, Yaginuma T, Matsuzaki H, Ozaki Y, Iriyama K.
    Exp Eye Res; 1987 Jul 17; 45(1):185-6. PubMed ID: 3115805
    [No Abstract] [Full Text] [Related]

  • 19. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H, Akagi Y, Yoshikawa T, Ikebe H, Takahashi Y, Chamoto K, Miyamoto Y, Terubayashi H.
    Nippon Ganka Gakkai Zasshi; 1987 Feb 17; 91(2):246-53. PubMed ID: 3111200
    [No Abstract] [Full Text] [Related]

  • 20. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
    Jacobson M, Sharma YR, Cotlier E, Hollander JD.
    Invest Ophthalmol Vis Sci; 1983 Oct 17; 24(10):1426-9. PubMed ID: 6413448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.